Guidelines: The National Clinical Cancer Care Guidelines (Sweden): Difference between revisions
m (Update categories.) |
No edit summary |
||
| Line 1: | Line 1: | ||
<span style="display:none">forproviders</span> | <span style="display:none">forproviders</span> | ||
<span style="display:none">forpolicymakers</span> | <span style="display:none">forpolicymakers</span> | ||
<span style="display:none">swedencountry</span> | |||
Go back to [[Sweden]] page | Go back to [[Sweden]] page | ||
Revision as of 17:26, 4 December 2025
Go back to Sweden page
Primary purpose: To ensure equal and high-quality care for all patients by providing evidence-based recommendations on the investigation, treatment, nursing, rehabilitation, and follow-up of patients with cancer.
Sponsor, manager or home institution: The National Clinical Cancer Care.
Type of information: Recommendations, screening, diagnosis, treatments, medical procedures, rehabilitation, palliative care, quality of life, medication use, check-up examinations and follow-up of patients with various types of cancer. Click here to learn more.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: Click here to access.